Lewes, DE -- (SBWire) -- 09/11/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Entropic Communications, Inc (NASDAQ:ENTR), Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC), Oncolytics Biotech, Inc. (USA)(NASDAQ:ONCY)

Entropic Communications, Inc (NASDAQ:ENTR) started its trading session with the price of $4.33 and closed at $4.20 by scoring -2.10%. ENTR’s stocks traded with total volume of 1.14 million shares, while the average trading volume remained 923,911 shares. The beta of ENTR stands at 2.48. Day range of the stock was $4.17 -$4.33.

Where ENTR is Headed Exactly? Find out in This Trend Analysis Reports

Entropic Communications, Inc., a fabless semiconductor company, designs, develops, and markets semiconductor solutions to enable home entertainment.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) ended its day with the gain of 1.09% and closed at the price of $14.86 after opening at $14.70. Stock traded during its last trading session with the total volume of 1.12 million shares, as compared to its average volume of 1.83 million shares.

What MDRX’s Charts Are Signaling for Traders? Find Out Here

Allscripts Healthcare Solutions, Inc. provides clinical, financial, connectivity, and information solutions a

nd related professional services to hospitals, physicians, and post-acute organizations primarily in the United States and Canada.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) opened its shares at the price of $3.54 for the day. Its closing price was $3.67 after gaining 8.26% for the day. The company traded with the total volume of 1.11 million shares, while its average trading volume remained 213,272 shares. The beta of CYCC stands at 2.02.

Can CYCC Show a Strong Recovery? Find out in This Research Report

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in the development and commercialization of mechanism-targeted drugs to treat human cancers and other serious diseases.

Oncolytics Biotech, Inc. (USA)(NASDAQ:ONCY) percentage change plunged -5.02% to close at $2.84 with the total traded volume of 1.11 million shares, and average volume of 359,537 shares. The 52 week range of the stock remained $1.60 - $4.93, while its day lowest price was $2.80 and it hit its day highest price at $3.07.

Should ONCY a Buy or Sell Now? Find Out Here

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers.

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/